14 results
CORRESP
ONCR
Oncorus, Inc.
11 Sep 20
Correspondence with SEC
12:00am
to select payloads and micro-RNA targets specific for brain cancer and anticipates being able to nominate a specific candidate in the second half
8-K
EX-99.1
ONCR
Oncorus, Inc.
10 Jan 22
Regulation FD Disclosure
8:17am
strain (Kuykendall) Targets ICAM expressing tumors Indications Patient Samples Tested (N) ICAM+ Prevalence NSCLC 97 72% HCC 69 72% RCC 67 79% Note … vRNA encoding for the synthetic Seneca Valley Virus (SVV) Targets SCLC & neuroendocrine prostate Induces tumor regression & improves survival
10-K
46ci4
10 Mar 21
Annual report
4:12pm
424B4
8bpat8u5i02n4bw4
2 Oct 20
Prospectus supplement with pricing info
12:00am
424B4
5uonl7mlnny0wmsu7
12 Feb 21
Prospectus supplement with pricing info
4:23pm
DRS
doi2o9a riz85
28 Jan 21
Draft registration statement
12:00am
DRS/A
s8johlyeqq9
26 Aug 20
Draft registration statement (amended)
12:00am
S-1
nqi8t3ji5kv4yrgeyp8
11 Sep 20
IPO registration
4:49pm
- Prev
- 1
- Next